- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- monomer
- Ligands
- 1 x SX0: (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}sulfanyl)butanoic acid (non-preferred name)(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 20 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.3: 4 residues within 4Å:- Chain A: A.19, K.205, W.206, W.209
Ligand excluded by PLIPUNX.4: 1 residues within 4Å:- Chain A: H.110
Ligand excluded by PLIPUNX.5: 1 residues within 4Å:- Chain A: R.102
Ligand excluded by PLIPUNX.6: 1 residues within 4Å:- Chain A: T.105
Ligand excluded by PLIPUNX.7: 1 residues within 4Å:- Ligands: UNX.8
Ligand excluded by PLIPUNX.8: 1 residues within 4Å:- Ligands: UNX.7
Ligand excluded by PLIPUNX.9: 3 residues within 4Å:- Chain A: S.104, L.107, K.212
Ligand excluded by PLIPUNX.10: 5 residues within 4Å:- Chain A: R.109, S.141, F.142, D.143
- Ligands: UNX.11
Ligand excluded by PLIPUNX.11: 3 residues within 4Å:- Chain A: S.141, F.142
- Ligands: UNX.10
Ligand excluded by PLIPUNX.12: 3 residues within 4Å:- Chain A: Y.184, R.232, T.236
Ligand excluded by PLIPUNX.13: 3 residues within 4Å:- Chain A: R.204, E.216, Y.217
Ligand excluded by PLIPUNX.14: 2 residues within 4Å:- Chain A: S.226, E.227
Ligand excluded by PLIPUNX.15: 3 residues within 4Å:- Chain A: R.230, Q.253, R.257
Ligand excluded by PLIPUNX.16: 2 residues within 4Å:- Chain A: H.252, K.255
Ligand excluded by PLIPUNX.17: 2 residues within 4Å:- Chain A: N.281, S.282
Ligand excluded by PLIPUNX.18: 2 residues within 4Å:- Chain A: Q.147, D.150
Ligand excluded by PLIPUNX.19: 3 residues within 4Å:- Chain A: K.188, L.225
- Ligands: SX0.1
Ligand excluded by PLIPUNX.20: 2 residues within 4Å:- Chain A: A.189, D.190
Ligand excluded by PLIPUNX.21: 2 residues within 4Å:- Chain A: H.118, E.202
Ligand excluded by PLIPUNX.22: 1 residues within 4Å:- Chain A: S.328
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yu, W. et al., Bromo-deaza-SAH: a potent and selective DOT1L inhibitor. Bioorg. Med. Chem. (2013)
- Release Date
- 2011-07-27
- Peptides
- Histone-lysine N-methyltransferase, H3 lysine-79 specific: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- monomer
- Ligands
- 1 x SX0: (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}sulfanyl)butanoic acid (non-preferred name)(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 20 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yu, W. et al., Bromo-deaza-SAH: a potent and selective DOT1L inhibitor. Bioorg. Med. Chem. (2013)
- Release Date
- 2011-07-27
- Peptides
- Histone-lysine N-methyltransferase, H3 lysine-79 specific: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A